Clinical trial 61186372GIC2002 ORIGAMI-1
A Phase 1b/2, Open-Label Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants with Advanced or Metastatic Colorectal Cancer
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/2 |
| Academic trial | Non |
| Sponsor | Janssen |
| EudraCT Identifier | 2021-006629-23 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05379595 |
| Last update |